112 related articles for article (PubMed ID: 37863068)
1. In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases.
Kerzel T; Giacca G; Beretta S; Bresesti C; Notaro M; Scotti GM; Balestrieri C; Canu T; Redegalli M; Pedica F; Genua M; Ostuni R; Kajaste-Rudnitski A; Oshima M; Tonon G; Merelli I; Aldrighetti L; Dellabona P; Coltella N; Doglioni C; Rancoita PMV; Sanvito F; Naldini L; Squadrito ML
Cancer Cell; 2023 Nov; 41(11):1892-1910.e10. PubMed ID: 37863068
[TBL] [Abstract][Full Text] [Related]
2. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
[No Abstract] [Full Text] [Related]
3. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.
Olino K; Wada S; Edil BH; Pan X; Meckel K; Weber W; Slansky J; Tamada K; Lauer P; Brockstedt D; Pardoll D; Schulick R; Yoshimura K
Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S597-607. PubMed ID: 21979110
[TBL] [Abstract][Full Text] [Related]
4. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model.
Vasquez M; Paredes-Cervantes V; Aranda F; Ardaiz N; Gomar C; Berraondo P
Oncotarget; 2017 Jan; 8(3):5247-5255. PubMed ID: 28029653
[TBL] [Abstract][Full Text] [Related]
6. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
7. In vivo macrophage engineering as novel therapeutic strategy against liver metastasis.
Laviron M; Guilliams M
Trends Cancer; 2024 Mar; 10(3):175-176. PubMed ID: 38355357
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
9. Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier.
Tran NL; Ferreira LM; Alvarez-Moya B; Buttiglione V; Ferrini B; Zordan P; Monestiroli A; Fagioli C; Bezzecchi E; Scotti GM; Esposito A; Leone R; Gnasso C; Brendolan A; Guidotti LG; Sitia G
Elife; 2022 Oct; 11():. PubMed ID: 36281643
[TBL] [Abstract][Full Text] [Related]
10. A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment.
Li M; Xing S; Zhang H; Shang S; Li X; Ren B; Li G; Chang X; Li Y; Li W
Oncol Rep; 2016 Mar; 35(3):1329-39. PubMed ID: 26752000
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the Generation of Eomes
Emerson DA; Rolig AS; Redmond WL
Cancer Immunol Res; 2021 Apr; 9(4):430-440. PubMed ID: 33593794
[TBL] [Abstract][Full Text] [Related]
12. Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8
Semmrich M; Marchand JB; Fend L; Rehn M; Remy C; Holmkvist P; Silvestre N; Svensson C; Kleinpeter P; Deforges J; Junghus F; Cleary KL; Bodén M; Mårtensson L; Foloppe J; Teige I; Quéméneur E; Frendéus B
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35058324
[TBL] [Abstract][Full Text] [Related]
13. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between IL-15Rα
Zhang W; Zhang Q; Yang N; Shi Q; Su H; Lin T; He Z; Wang W; Guo H; Shen P
Cancer Commun (Lond); 2022 Jun; 42(6):536-557. PubMed ID: 35615815
[TBL] [Abstract][Full Text] [Related]
15. The combination of PD-1 blockade with interferon-α has a synergistic effect on hepatocellular carcinoma.
Zhu Y; Chen M; Xu D; Li TE; Zhang Z; Li JH; Wang XY; Yang X; Lu L; Jia HL; Dong QZ; Qin LX
Cell Mol Immunol; 2022 Jun; 19(6):726-737. PubMed ID: 35459855
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
Yu P; Steel JC; Zhang M; Morris JC; Waitz R; Fasso M; Allison JP; Waldmann TA
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6187-92. PubMed ID: 22474386
[TBL] [Abstract][Full Text] [Related]
17. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma.
Patterson MT; Burrack AL; Xu Y; Hickok GH; Schmiechen ZC; Becker S; Cruz-Hinojoza E; Schrank PR; Kennedy AE; Firulyova MM; Miller EA; Zaitsev K; Williams JW; Stromnes IM
Cell Rep; 2023 Jul; 42(7):112732. PubMed ID: 37402168
[TBL] [Abstract][Full Text] [Related]
19. Cordycepin synergizes with CTLA-4 blockade to remodel the tumor microenvironment for enhanced cancer immunotherapy.
Chen L; Zheng X; Huang H; Feng C; Wu S; Chen R; Jiang H; Yuan M; Fu Y; Ying H; Zhou J; Jiang J
Int Immunopharmacol; 2023 Nov; 124(Pt A):110786. PubMed ID: 37611443
[TBL] [Abstract][Full Text] [Related]
20. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment.
Catarinella M; Monestiroli A; Escobar G; Fiocchi A; Tran NL; Aiolfi R; Marra P; Esposito A; Cipriani F; Aldrighetti L; Iannacone M; Naldini L; Guidotti LG; Sitia G
EMBO Mol Med; 2016 Feb; 8(2):155-70. PubMed ID: 26769348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]